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Abstract (250)  
Aim: to describe the frequency, characteristics and treatment outcome of persistent 
fetal vasculature (PFV) in children undergoing surgery for congenital and infantile 
cataract in the first two years of life  
Methods: observational population based cohort study with case identification 
through active surveillance and standardised data collection via a national clinical 
network, the British Isles Congenital Cataract Interest Group (BCCIG) 
Results: The IoLunder2 cohort comprises 246 children undergoing surgery for 
bilateral and unilateral congenital and infantile cataract in the first two years of life. 
58/246 (24%)children had persistent fetal vasculature %):  overall, 46/95 (46%) with 
unilateral cataract, and 12/141(8%) with bilateral disease. Anterior segment vascular 
remnants were more common in bilateral than unilateral disease (75% versus 11%, 
p=0.01). At one year after surgery, 20% of children with bilateral PFV and 24% with 
unilateral had achieved normal vision for age within the operated eye. The 
prevalence of post operative glaucoma was 9% (of children with bilateral disease) 
and 4% (unilateral).  
Conclusions: persistent fetal vasculature is significantly more common than 
previously reported, and outcomes are comparable to that for congenital and infantile 
cataract overall.   
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Persistent fetal vasculature, or PFV, comprises a spectrum of clinical features 
caused by failure of the normal process of regression or apoptosis of the fetal 
intraocular vasculature which usually occurs during the second trimester. PFV was 
previously termed persistent hyperplastic primary vitreous (PHPV), due to the 
characteristic feature of a plaque of remnant tissue sitting on the posterior face of a 
cataractous lens, attached to a persistent stalk of hyaloid vasculature. However, any 
part of the fetal vasculature can persist, resulting in iris, pupillary, or optic nerve 
vascular remnants.(1) Congenital pupillary fibrovascular membranes, rather than 
being a separate entity, are histopathologically similar to the retrolenticular 
manifestations of PFV.(2)  
Cataract is a frequent secondary event in PFV, due to invasion of the vascular 
remnants, lenticular swelling, intralenticular haemorrhage, or calcification.(1,3) PFV 
features have been found in a fifth of cases of unilateral congenital or infantile 
cataract, but are much less commonly noted in bilateral cataract.(4) Cataract surgery 
in children with PFV is associated with a higher incidence of adverse events and 
worse outcome.(5;6) In addition, bilateral cases of PFV may be associated with 
systemic abnormalities which impact on a child’s global development.(1;7)  
The British Isles study of primary intraocular lens implantation in children under 2 
with congenital or infantile cataract (IoLunder2) is a prospective observational cohort 
study, undertaken through the British Isles Congenital Cataract Interest Group 
(BCCIG) a collaborative clinical research network of ophthalmologists involved in the 
management of children with congenital and infantile cataract. IoLunder2, which 
comprises a nationally representative group of children who have undergone 
cataract extraction with or without intraocular lens implantation in the United 
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Kingdom and Ireland, aims to describe treatment outcomes and determine the 
predictors of outcome. We report here on the morphology of persistent fetal 
vasculature and outcomes following surgery within this cohort.  
 
Methods 
Children eligible for inclusion into the IoLunder2 study were those resident in the 
British Isles undergoing primary surgery for congenital or infantile cataract in the first 
two years of life. Active surveillance was undertaken over a two year study period 
(January 2009 to December 2010) through a national clinical network, the British 
Isles Congenital Cataract Interest Group (BCCIG). Following parental consent, 
standardised data collection using a structured proforma was undertaken through the 
network. The IoLunder2 study methodology has been reported in detail 
previously.(8) 
A standardised classification of the presence and morphology of PFV was developed 
for the study.  PFV was classified within one of these three mutually exclusive 
categories using an anatomically derived taxonomy (see e-supplement):  
1.Isolated posterior capsular plaque / persistent posterior tunica vasculosa  
2. Anterior PFV only (persistent iridohyaloid / pupillary membrane / anterior tunica 
vasculosa) 
3.Complex PFV (posterior plaque plus other manifestation) 
Within the complex PFV category, the presence of other signs (anterior PFV, 
persistent hyaloid artery, centrally dragged ciliary processes, optic nerve head 
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hypoplasia / dysplasia, macular abnormalities, retinal detachment) were 
dichotomised as present or absent. 
Statistical analyses were performed using STATA SE 10/11 (Stata Corp, Chicago 
Illionois). Children with unilateral cataract were analysed separately from those with 
bilateral disease. Findings of descriptive analysis are presented as proportions for 
binary or categorical data, with 95% confidence intervals where appropriate.   
Ethics and research governance approval was granted by the relevant UK / Ireland 
bodies, and the research adhered to the tenets of the Declaration of Helsinki.  
 
Results:  
254 (83%) of eligible children were recruited into IOLunder2. Complete pre and per 
operative data are available for 246, and post-operative outcomes at one year 
following surgery were available for 221. Persistent fetal vasculature was present in 
58 of the 246 children (23.6%, table 1):  46 of the 99 children with unilateral cataract 
(46.5%, 95% confidence interval CI 36 to 56%), and a significantly lower proportion 
of children with bilateral cataract (12/147 children, 8.2%, 95% CI 0 to 24%). 
Compared to other children with unilateral congenital and infantile cataract, those 
with persistent fetal vasculature presented to clinicians at a similar age. All children 
with unilateral congenital cataract associated with PFV had negative family histories 
for congenital cataract. Compared to other children with bilateral cataract, diagnosis 
of PFV cataract occurred at a later age, children were less likely to have a family 
history of cataract, and more likely to be affected by a systemic disorder or anomaly, 
although these differences did not reach statistical significance (table 2).  
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Table 1. Classification of persistent fetal vasculature in bilateral and unilateral 
congenital and infantile cataract 
 Bilateral  Unilateral  Total  
Number of children 147 99 246 
Number of children with PFV 
% of children 
12 46 58 
8.2% 46.5% 23.6% 
  Isolated retrolental PFV 
% of children with PFV 
2 19 21 
 17%  43%  37% 
 Anterior PFV 
% 
4 3 7 
 33%  7% 13%  
  Complex PFV 
% 
6 23 29 
 50%  50% 50% 
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Manifestations of PFV in unilateral and bilateral cataract  
The most common finding in PFV associated unilateral cataract was persistent 
posterior tunica vasculosa lentis (PTVL), manifesting as either a posterior plaque or 
membrane (41 children, 92%) (figure 1a). However, for half of all children with a 
persistent hyaloid artery (9/18), there was no other retrolental vascular manifestation 
(figure 1a). Bilateral PFV was more likely to have present as something other than 
the classic retrolental plaque: in comparison to children with unilateral PFV, a 
significantly higher proportion of children with bilateral PFV associated cataract had 
iris, pupil or anterior capsular vascular remnants (75% versus 11%, chi2  test for 
difference between proportions or DIP p=0.01, 95% CI DIP 21% - 71%). Bilateral 
PFV also showed evidence of within child phenotypic variation: in 2 of the 7 cases of 
bilateral PFV, children had asymmetric manifestations of persistence in both eyes. 
In comparison to congenital and infantile cataract with no evidence of PFV, bilateral 
and unilateral cataract eyes with evidence of persistent vasculature were no more 
likely to be microphthalmic. No child with bilateral disease had stretched ciliary 
processes, whilst 8 children (18%, 95% CI 7-29%) with unilateral PFV exhibited 
ciliary process traction (figure 1b).  
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Table 2. Clinical characteristics and outcome for children with persistent fetal vasculature related cataract versus cataract without 
PFV  
 
PFV associated 
unilateral cataract 
 
n=46 
Unilateral cataract 
without PFV 
 
n=53  
PFV associated 
bilateral cataract 
 
n=12 
Bilateral cataract 
without PFV  
 
n=129 
Median age at diagnosis  
(range in days) 
13 days 
(1 – 671) 
16 days 
(0 - 486) 
49 days 
(2 – 275) 
6 days 
(0-586) 
Positive family history of cataract 
(95% CI) 
0% 
(0-1) 
9%* 
(1-16) 
25% 
(1-50) 
45% 
(36-54) 
 
Cataract 
morphology  
Posterior lenticular 
opacity, % (95% CI) 
61%  
(47-75) 
19%* 
(8-30)  
42% 
(14-70)  
10%  
(5-15) 
Anterior lenticular 
opacity, %  
1% 9% 8% 3% 
Other, %  38% 72% 50% 87% 
Prevalence of non-ophthalmic systemic 
disorder 
(95% CI) 
4% 
(0-10) 
7% 
(1-14) 
58% 
(31-86) 
20% 
(13-27) 
Median axial length in mm 
(range) 
18.1 
(15-22.9) 
18.5 
(15.3 – 23.9) 
18.0 
(15.4 – 24.1) 
17.5 
(13.3 -  23.5) 
Median horizontal corneal diameter in mm 
(range) 
10.25  
(8-12) 
10.5  
(9-12.5) 
9.5  
(7-12) 
10  
(7.25 – 12)  
Median age at surgery  
(range) 
9 weeks 
(4- 100) 
9 weeks   
(2 – 95) 
19 weeks 
(4-64) 
10 weeks  
(2 – 101) 
Proportion undergoing IoL implantation  
(95% CI) 
35% 
(21- 49) 
70%* 
(57 – 82) 
33% 
(7-60) 
41% 
(33-50) 
*significant difference (p<0.05) between children with and without PFV  
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Systemic disorders in children with PFV related cataract  
5 of the 46 (11%) children with unilateral cataract associated with PFV were also 
affected by a non-ocular disorder or anomaly (table 2). These systemic abnormalities 
comprised: congenital toxoplasmosis, trisomy 21, haemophilia, and in two children 
for whom a formal diagnosis is awaited, lower intestinal and genitourinary 
malformations, and atrioseptal congenital cardiac anomaly. The child with congenital 
toxoplasmosis manifested complex PFV, whilst the other 4 children had isolated 
posterior hyaloid stalks.  
 
Over half of the children, 7 / 12, with bilateral cataract and PFV had systemic 
disorders (table 3). 3 children had hereditary ocular or systemic disease, but for the 
majority of children with a systemic disorder a formal diagnosis or genotype has yet 
to be determined.  
 
Outcomes following surgery for cataract associated with persistent fetal vasculature  
All children with persistent fetal vasculature underwent primary surgery involving 
anterior capsulotomy, lens aspiration, primary posterior capsulotomy and primary 
anterior vitrectomy. Patent hyaloid stalks underwent diathermy prior to stalk division. 
16/46 unilateral PFV eyes (35%), and 4/12 eyes of children with bilateral PFV (33%) 
underwent primary IOL implantation. 1 year following surgery for unilateral PFV 
cataract, 24% of operated eyes had achieved vision within normal range for age 
(95% CI 12-36) and 10% had only perception of light vision or worse (CI 1-19%). The 
proportion children with  bilateral PFV cataract achieving normal vision in the better 
eye or with both eyes open was 20% (CI 0-43%) and all children had vision better 
than perception of light. The subgroup of children with complex PFV achieved 
Running title: Congenital cataract and PFV  
 
relatively poorer outcomes. No child with optic nerve head or retinal involvement 
achieved vision within the normal range for age 1 year after surgery, compared to 
35% (CI 20-47%) of children with unilateral PFV not affecting the fundus. 
 
No child with congenital cataract related PFV was diagnosed with glaucoma pre-
operatively, and during the first post-operative year secondary glaucoma was 
diagnosed in 4% of children with unilateral (n=2, 95% CI 0-10%) and 9% with 
bilateral PFV cataract (n=1, 95% CI=0-15%).Of the two unilateral cases which 
developed secondary glaucoma, one had a posterior plaque only, the other a plaque 
and stalk. The bilateral cases had posterior plaque only. The frequency of post-
operative glaucoma was not higher for eyes with anterior manifestations of PFV in 
either bilateral or unilateral cataract.  
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Table 3. Details of persistent fetal vasculature manifestation, identified aetiology and 
systemic disorders in bilaterally affected children 
 Right eye 
manifestation  
Left eye 
manifestation  
Systemic disorder / anomaly and 
final  diagnosis 
1 PTVL – bilateral plaque 
Dysmorphia, congenital 
arterioseptal defect, cleft palate, no 
formal diagnosis  
2 
PTVL – bilateral plaque and hyaloid artery  
 
Macrocephalus, no formal 
diagnosis  
3 
ATVL – bilateral iris and anterior capsule 
remnant  
WAGR Chromosome 11 deletion  
4 
ATVL – bilateral congenital pupillary 
membrane 
Dysmorphia, hypospadias, no 
formal diagnosis 
5 
PTVL & ATVL – bilateral plaque and iris 
remnants 
Neonatal frontal lobe infarct  
6 PTVL – plaque 
PTVL & ATVL – 
plaque and iris 
remnants  
Cerebral atrophy, no formal 
diagnosis 
7 PTVL – plaque 
PTVL & ATVL – 
plaque, hyaloid artery 
and iris remnants  
Congenital facial palsy 
 
PTVL: Posterior tunica vasculosa lentis 
ATVL: Anterior tunica vasculosa lentis 
WAGR: Wilms tumour Aniridia Genitourinary Retardation syndrome 
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Discussion 
We have found that the proportion of children who undergo surgery for congenital 
cataract associated with PFV is significantly higher than previously reported, even 
allowing for the widening of the definition of PFHV from that of PHPV. 42 of the 95 
children with unilateral cataract (44%) within this present cohort would previously 
have been diagnosed with persistent hyperplastic primary vitreous, which remains a 
significantly higher proportion. This is unlikely to reflect a ‘true’ increase in the 
incidence of PFV, as such a rise would require a dramatic biological influence. 
Instead, our findings suggest that there is improved clinical recognition of the signs 
of persistent fetal vasculature. Furthermore, features of PFV may only be visible 
during removal of the cataractous lens, and children with persistent fetal vasculature 
may present earlier in life. Thus a study which recruits children undergoing surgery in 
early life may report a higher frequency of affected children. An Austrian study which 
prospectively recruited 31 children aged 0 – 15 years old with unilateral cataract 
reported that all had some feature of persistent vasculature.(7) Two large scale 
population based studies have described PFV as only affecting a relatively low 
proportion of children with cataract. Rahi et al reported that 22% of children aged 0 -
15 years diagnosed with unilateral congenital or infantile cataract in a national study 
were affected by PFV,(9) and investigators in Toronto reported the frequency to be 
11% in children aged under 16 years at surgery for unilateral cataract.(10) These 
study populations described children diagnosed at any age with congenital and 
infantile cataract. This difference from the IoLunder2 study may partly explain the 
observed differences in frequency of PFV, as children with PFV manifestations may 
be diagnosed earlier than those without. The converse was, however, true for the 
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IoLunder2 cohort where PFV was associated with later diagnosis in bilateral 
cataract.   
36% of children with bilateral cataract, and 20% of those with unilateral cataract 
within the IoLunder2 cohort achieved normal vision for age within the operated eye 
one year following surgery.(8) For the majority of children with congenital cataract 
associated with PFV, there is no evidence of worse outcome when compared to 
reported outcomes for the wider group of children within the IoLunder2 cohort. Other 
investigators have theorised that the ocular maldevelopment secondary to failure of 
vascular regression results in worse functional and structural outcomes,(1;5) with 
worse vision for affected children and higher rates of post-operative glaucoma, and 
previous studies have reported a higher rate of per and  post-operative complications 
in eyes affected by PFV,(6) but within IoLunder2 the only association with poor 
outcome was for those with optic nerve head or retinal anomalies in associated with 
PFV. Congenital and infantile cataract per se are reflections of significant insult to 
lens development, and it may be that there is no ‘summative’ negative impact from 
the additional presence of persistent vasculature. The early outcomes from 
IoLunder2 should be broadly predictive of later outcomes,(11) although more cases 
of post-operative glaucoma are likely to emerge.(12)  
Stretched ciliary processes were once considered pathognomic for PFV,(3) but are 
now known to be present in other vitreoretinopathies such as retinopathy of 
prematurity or vitreoretinal dysplasia.(1) Our findings suggest that children with 
bilateral PFV are less likely to have ciliary traction, but also more likely to have 
anterior segment manifestations, and more likely to have a non-ophthalmic disorder, 
but the significance of this is unclear. There may be different pathogenetic pathways 
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involved for children with bilateral and unilateral disease.  Emerging evidence 
suggests that in the majority of children affected by bilateral congenital and infantile 
cataract where there is no obvious associated ‘syndrome’, it is possible to identify a 
plausible pathogenic single gene mutation.(13)The aetiology of PFV is poorly 
understood, but animal models have identified a role for the failure of both the 
macrophage orchestrated extrinsic apoptotic pathway(14) and the tumour 
suppressor gene intrinsic apoptotic pathway(15) in the pathogenesis of the 
persistence of the nutrient fetal vasculature. One gene complex implicated in the 
failure of ocular fetal vasculature apoptosis via the intrinsic pathway is 
frizzled/wnt(16), which codes for a transmembrane protein. This protein is also 
implicated in the allelic congenital human retinal vascular development disorders of 
Norrie disease and familial exudative vitreoretinopathy, with the latter being 
described clinically as a ‘hereditary form of retinopathy of prematurity (ROP)’. It has 
also been suggested that PFV is a result of failure of apoptosis due to reduced 
exposure to VEGF. This pathway has been supported by the changing patterns of 
VEGF receptors on mammalian fetal intraocular vasculature,(17) and is a pathway of 
current clinical interest due to the use of VEGF inhibitors as treatment for ROP. 
Primary prevention of unilateral cataract is an important goal as visual outcomes for 
unilateral remain poor. Understanding the aetiology and pathogenesis of PFV may 
contribute to this aim, and may increase the understanding of the vascularisation of 
the fetal retina and possibly of the entire fetal cerebral system. PFV is thus a worthy 
candidate for future genetic research but will require meticulous ‘phenotyping’, ie 
detailed description of morphology with pre-operative clinical imaging, ahead of 
investigation into genetic markers of the disorder. 
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Prompt diagnosis affording prompt treatment remains the most important 
management intervention for achieving good visual outcomes in congenital and 
infantile cataract. The early age at diagnosis for the majority of children with PFV 
related congenital cataract can be considered as an indicator of the success of the 
UK’s ocular anomaly screening programme. Children undergo a red reflex test within 
72 hours of birth, and a second examination with their general practitioner (family 
doctor) as part of the 6-8 week infant physical examination screening. However, this 
cohort consists only of children who have undergone cataract surgery. There may be 
a small number of children who did not undergo cataract surgery as late diagnosis 
had resulted in amblyopia sufficiently dense to be unlikely to respond successfully to 
treatment. 6 children (50%) with bilateral PFV cataract were diagnosed after 8 weeks 
of age. It is unclear whether these represent cases of ‘late’ diagnosis, or whether 
cases were diagnosed at a later age following progression of PFV related lens 
opacity.    
The IoLunder2 study is able to provide population level data on the prevalence and 
manifestations of persistent fetal vasculature within children undergoing surgery for 
congenital and infantile cataract in the first two years of life, better informing 
clinicians on the characteristics and outcomes of this complex and uncommon 
disorder. On going follow up of this cohort will provide natural history and outcomes 
for children who have undergone surgery for PFV related cataract.  
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Titles and legends to figures 
E-supplement). The intraocular fetal vasculature 
This anastamotic nutrient network disappears by full term birth.  
 
Figure 1a and 1b. Relative frequencies and patterns of manifestation of the different 
features of PFV in a) unilateral and b) bilateral cataract  
 
What was known before 
Persistent fetal vasculature may affect a fifth of children with unilateral congenital or 
infantile cataract  
Persistent fetal vasculature may be associated with poorer outcomes for babies and 
infants with cataract  
What this study adds 
Almost half of all children who undergo surgery unilateral congenital and infantile 
cataract, and a tenth of those with bilateral cataract have PFV 
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Positive family history is an uncommon finding in unilateral PFV related cataract 
Most children with bilateral PFV also have a non-ophthalmic disorder  
Outcomes, particularly in unilateral cataract, are similar for children with or without 
PFV 
 
 
  
 
